Continuous administration of olmesartan (RNH6270) attenuates lung expression of inflammatory factor(s) with reduced mortality but no-amelioration of pulmonary hypertension in monocrotaline-treated rats
JOURNAL OF PHARMACOLOGICAL SCIENCES（2014）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined